Showing results (51-60 of 219) with videos related to

Sort By:
Pageof 22
Current Opinion in Rheumatology|May 16, 2014
Infectious triggers for vasculitisMirjan M van Timmeren, Peter Heeringa, Cees G M Kallenberg
Seminars in Respiratory and Critical Care Medicine|August 10, 2005
Pathogenesis of pulmonary vasculitisPeter Heeringa, Adrian Schreiber, Ronald J Falk, et al.
Trends in Endocrinology and Metabolism: TEM|September 6, 2023
Mechanisms and pathophysiology of SARS-CoV-2 infection of the adipose tissueJill Moser, Marloes Emous, Peter Heeringa, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 23, 2015
Maintenance therapy in antineutrophil cytoplasmic antibody-associated vasculitis: who needs what and for how long?Anoek A E de Joode, Jan Stephan F Sanders, Abraham Rutgers, et al.
Frontiers in Immunology|October 30, 2014
T cells in vascular inflammatory diseasesLucas L Lintermans, Coen A Stegeman, Peter Heeringa, et al.
Rheumatology (Oxford, England)|March 12, 2025
Highlights from the plenary session: cellular and molecular mechanisms of disease (I)Jonas Zimmermann, Adrian Schreiber, Peter Heeringa, et al.
Plos One|March 26, 2011
Reactivity against complementary proteinase-3 is not increased in patients with PR3-ANCA-associated vasculitisHenko Tadema, Cees G M Kallenberg, Coen A Stegeman, et al.
Autoimmunity Reviews|August 23, 2011
Immune regulatory mechanisms in ANCA-associated vasculitidesNikola Lepse, Wayel H Abdulahad, Cees G M Kallenberg, et al.
Scientific Reports|April 28, 2025
Elevated Fab glycosylation of autoantibodies maintained during B cell depletion therapyAnika M Valk, Jana Koers, Ninotska I L Derksen, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|July 2, 2013
Pathogenesis of ANCA-associated vasculitis: new possibilities for interventionCees G M Kallenberg, Coen A Stegeman, Wayel H Abdulahad, et al.
Pageof 22